From: Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides
Parameters | Characteristics |
---|---|
Number of volunteers | 20 |
Mean age (range) | 30.1 years (23–45) |
Male /Female (nb/nb) | 7 / 13 |
Allergic asthma (nb) | 7 |
Allergic rhinitis (nb) | 20 |
Mean peak expiratory flow rate (% predicted value, L/min) (range)* | 93.75 (61–117) |
Mean anti-birch pollen IgE (kU/L) (range) | 29.34 (0.7 – 100) |
Mean anti-rBet v 1 IgE (kU/L) (range) | 29.48 (0.35 - 100) |